Navigation Links
Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology
Date:9/2/2014

Philadelphia, PA (PRWEB) September 02, 2014

Opertech Bio, Inc., a company that has pioneered a new highly efficient, cost effective approach to sensory evaluation, today announced the issuance of U.S. Patent No. 8,820,265 by the U.S. Patent and Trademark Office, encompassing high-throughput sensory discrimination technologies proprietary to Opertech.

“Opertech’s taste evaluation technology called Microtiter Operant Gustometer or MOG, is the first automated high throughput system for rapid characterization of taste sensory properties,” said R. Kyle Palmer, Opertech’s Chief Science Officer and inventor of the technology. “Before MOG, taste testing required many subjects, large amounts of test samples, and days to weeks for evaluation of only a few samples—all adding up to extensive expenditures in resources and dollars. MOG accomplishes the task on hundreds of samples in an afternoon, using far fewer subjects and much less sample at a fraction of the cost and with greater accuracy and consistency than previously possible,” he added.

Opertech’s proprietary technologies capture both hedonic (appetitiveness/aversiveness, or palatability) as well as chemosensory quality information from large numbers of samples in a short period of time. For example, Opertech’s MOG can be configured to accommodate a standard microtiter plate (a pharmaceutical 96-well plate) from which individual samples are dispensed/presented one at a time to a subject for evaluation with hedonic and chemosensory quality information captured/recorded for each sample in a short period of time (e.g., 96 samples can be tested and a sensory response recorded for each sample in 90 minutes or less).

The MOG Approach to Taste Evaluation

MOG is an entirely new approach to taste testing and measurement for both humans and animals. MOG is an automated high throughput system with the capacity to determine the taste characteristics of hundreds of samples in less than an hour. Testing with MOG does not rely on subjective rating scales of taste sensation and can be performed with 3 to 4 subjects for either humans or animals. Taste sample sizes are small—a fraction of the amounts required for traditional taste tests—translating to dramatic savings in costs associated with synthesizing or purifying new ingredients.

More data means greater informative power. The comparatively large data sets that are rapidly generated by MOG are amenable to sophisticated computational and analytic tools not practical for the limited information from traditional taste assessment. Among the many advantages that result are vastly reduced errors, greater precision in detecting taste effects, improved consistency and predictive value of test outcomes, and the ability to more quickly and broadly test across a diversity of human subjects.

About Opertech Bio, Inc.:

Opertech Bio has developed a revolutionary approach to taste testing, a multi-billion dollar market covering the food and beverage, flavor ingredients, pet food, and pharmaceutical industries. Opertech Bio’s technology can be used to discover new flavor ingredients, measure palatability, and optimize flavor formulations. For more information, please visit the company's website at http://www.opertechbio.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12123258.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Opertech Bio Researchers Develop Method For High-Throughput Taste Evaluation
2. DIANA and Opertech Bio Announce Collaboration in Taste Science
3. UCSB professor receives award for graphene electronics research
4. Watsons Generic Yaz(R) Receives FDA Approval
5. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
6. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Intimate Bridge 2 Conception, Inc. Receives $4.3M
9. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
10. BioNeutral Group Receives $400,000 in Equity Financing
11. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... is now being assessed in clinical trials in the United States. (clinicaltrials.gov : ... your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ ...
(Date:9/21/2017)... , ... September 21, 2017 , ... Dr. Greg Leyer, ... Vegas, NV on September 27th. His presentation is at 12:10pm in the Probiotics Resource ... to present at SupplySide West and discuss how probiotics have shown impressive data in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Colpitts Clinical has launched the ... includes new features that facilitate streamlined and compliant communication, file sharing and document ... forefront of medical advancements, they rely on efficiencies to help them address the ...
(Date:9/21/2017)... New Jersey (PRWEB) , ... September 21, 2017 ... ... highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 ... Part 11 training - Compliance with Regulation 21 CFR Part 11 on ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):